JOURNAL OF INFECTIOUS DISEASES, vol.217, no.8, pp.1184-1192, 2018 (SCI-Expanded)
Background. Interferon is the only treatment option in chronic delta hepatitis (CDH). A CDH database (333 patients, 161 with interferon treatment history) was analyzed for effects of treatment duration on virologic response and clinical outcomes.